%1$s

Dr. Anilkumar Mannava Consultant Gastroenterologist and Hepatologist

Dr. Anilkumar Mannava

Dr. Anilkumar Mannava

MD (General Medicine), DNB (Gastroenterology)

Department: Gastroenterology
Designation: Consultant Gastroenterologist and Hepatologist
Years Of Experience: 10
Location: Secunderabad
Languages: Telugu, Kannada, English, Hindi
Med Reg No: 66711
Book An Appointment

Dr. Anil Kumar Mannava is one of the leading Gastro specialists with an experience of about 9 years in treating various diseases related to Gastrointestinal tract. He focuses on diagnosing and managing symptoms of patients and improving their quality of life. In the field of clinical research, he has been a principal investigator in gastrointestinal research and a co-investigator in randomized clinical study of drug therapy in Hepatitis.

He completed his medical education from Dr. Pinnamaneni Siddhartha Institute of Medical Sciences & RF. He also received his MD in General Medicine from Sri Devaraj Urs Medical College, Kolar and DNB in Gastroenterology in Hyderabad. He has various articles published in renowned Medical Journals to his credit.

Education Qualifications

Education Qualifications

  • DNB (Gastroenterology): Global Hospital, Lakdikapul, Hyderabad, 2018
  • MD (General Medicine): Sri Devaraj Urs Medical College, Kolar ( Sri Devaraj Urs University, Kolar, Karnataka), 2014
  • MBBS: Dr. Pinnamaneni Siddhartha Institute of Medical Sciences & RF, Gannavaram, Vijayawada, AP. (NTR University of Health Sciences, Vijayawada, AP , India), 2010
ExperienceExperience
  • Consultant Gastroenterologist and Hepatologist, Yashoda Hospitals, 2020
  • Consultant Gastroenterologist: Department of Medical Gastroenterology and Hepatology, Global Hospital, Lakdikapul, Hyderabad, 2019
  • Senior Resident: Department of General Medicine, KMC, Mangalore, May 2015-March 2016
  • Senior Resident: Department of General Medicine, KMC Manipal, June 2014-Jan 2015
  • Junior Resident: Department of General Medicine, Sri DevarajUrs Medical College, Kolar, Karnataka, India, May 2011-May 2014
Services offeredServices offered
  • Therapeutic Endoscopy & Colonoscopy
  • Therapeutic ERCP
  • Spyglass Cholangioscopy
  • Interventional Biliary and Pancreatico EUS
  • PerOral Endoscopic Myotomy (POEM)
  • 3rd Space Endoscopy
  • Endoscopic Mucosal Resection (EMR)
  • Endoscopic Mucosal Dissection ( ESD)
Special Interest and ExpertiseSpecial Interest and Expertise
  • Therapeutic Endoscopy
  • ERCP, EUS
  • Third Space Endoscopy
  • Endoscopic Bariatric Procedures
  • Research in field of Gastroenterology and Hepatology
Research & PublicationsResearch & Publications
  • Prevalence of Functional Dyspepsia in a Rural medical college hospital. Venkatarathnamma P. N, Anil Kumar Mannava, Ujjawal Kumar, Chethan, Reethesh R. P. 2014;3(8):1934-39. J of Evolution of Med and Dent Sci.
  • Jaundice evaluation in medical wards, study in a rural medical college hospital in South India. AnilkumarMannava, Venkatarathnamma P N. 2014;2(3): 217-220. Journal of Biological and Scientific Opinion
  • Acute Methemoglobinemia Due To Nitrobenzene Poisoning: Case Series. Harish Kumar S,Ujjawal Kumar, Raghavendra Prasad BN, Kiran BJ, Anil Kumar M. 2014;3(2):464-467. Int J Med Res Health Sci.
  • Prabhakar k, Jayarama N, Pavithra L, Anilkumar M. A rare case of Snake bite with severe isolated hematotoxicity: Case Report. J Clin Biomed Sci. 2011; 1 (4) 173-77
  • Prevalence of Functional Dyspepsia in a Rural medical college hospital. At Kapicon 2012- 30th Annual Conference of API- Karnataka Chapter held at Hassan.
  • Intensive Care Unit admission characteristics and outcome among elderly and very elderly patients.at Kapicon 2013- 31st Annual Conference of API- Karnataka Chapter held at Mangalore.
  • Study of correlation of Insulin Resistance and dyslipidemia in patients with Non Alcoholic Fatty Liver Disease at KRSSDI 2014, held at Belgaum.
  • Prevalence of Single Nucleotide Polymorphisms in PNPLA3, APOC3 and TM6SF2 Genes in Non Alcoholic Fatty Liver Disease. At APDW 2019 held in Kolkata from December 11-15 , 2019
  • Sudden onset of sensorineural hearing loss as a complication of Type1 Diabetes Mellitus following an episode of DKA. Presented at Kapicon 2012- 30th Annual Conference of API- Karnataka Chapter held at Hassan
  • Jaundice evaluation in medical wards, study in a rural medical college hospital in South India. Presented at Apicon 2013- 68th Annual Conference of API held at Coimbatore
  • Anilkumar Mannava, Dharmesh Kapoor. Management of a patient waitlisted for Liver transplant. Published in year book of ISGCON 2017
  • Anilkumar Mannava, Dharmesh Kapoor. Beta Blockers in cirrhosis of liver. Published in Gastroenterology Update book published by ISG in 2018
  • Anilkumar Mannava, Dharmesh Kapoor. Acute Liver failure. In: Rajiv Mehta, eds. Clinical Gastroenterology. 4th ed. India: Paras Medical Publisher; 2020.
  • Anilkumar Mannava, Dharmesh Kapoor. Renal dysfunction in Chronic liver disease. In: Rajiv Mehta, eds. Clinical Gastroenterology. 4th ed. India: Paras Medical Publisher; 2020
  • Multicentre, Open Label, Prospective Phase IV Study to Evaluate the Safety and Efficacy of Fixed Dose Combination (FDC) of Sofosbuvir/Daclatasvir in Adults with Genotype 3 Chronic Hepatitis C Virus Infection in India Protocol Id: MYL-MHD-4001
  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH). Protocol Id: GS-US-384-1944
  • A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis. Protocol Id:GS-US-384-1943
  • Multicenter, Open Label, Prospective, Phase IV Interventional Study in Adult Indian Patients to Evaluate the Safety and Efficacy of MyHep LVIRTM (ledipasvir/Sofosbuvir, Fixed Dose Combination) in HCV genotype 1 infection and the combination of MyHepTM (Sofosbuvir) and MyDeklaTM (daclatasvir) in HCV genotype 3 infections. Protocol Id: MYL-SLD-4001
  • A multicenter, open label, single arm, prospective, Phase IV study to evaluate the safety and efficacy of MyHep All™ (Sofosbuvir/ Velpatasvir, fixed dose combination) in Indian Adult patients with chronic Hepatitis C Virus (HCV) infection. Protocol Id: MYL-MYV-4001
  • A Phase 3, Randomized, Double-Blind Study to Evaluate theSafety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg Positive, Chronic Hepatitis B. Protocol Id: GS-US-320-0110
  • A Multicenter, Prospective,Observational, Post Marketing Surveillance Study to Evaluate the Safety and Efficacy of Sofosbuviur based Regimens in Clinical Practice for the Treatment of Patients with Chronic Hepatitis C Virus infection in india Protocol Id: GS-US-334-1775
  • A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 weeks in Subjects with Chronic Hepatitis C Virus (HCV) infection. GS-US-342-1521

Contact

  • Yes Same as WhatsApp number
  • By clicking on Send, you accept to receive communication from Yashoda Hospitals on email, SMS and Whatsapp.
×
X
Select Department
Not Sure of the Specialty?
X

Choose your date & Slot

Change Date
Monday, OCTOBER 30
Enter Patient Details

Please Note: This session ends in 3:00 mins

Not Finding Your Preferred Slots?